Valneva Aktie
2,08
EUR
-0,05
EUR
-2,35
%
2,16
EUR
-0,55
EUR
-20,34
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele im Branchenvergleich
Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
---|---|---|---|---|---|
Amgen Inc. | 0 | 0 | 0 | - | - |
AstraZeneca PLC | 5 | 4 | 0 | 135,44 GBP | - |
BB Biotech AG | 0 | 0 | 0 | - | - |
BioNTech (ADRs) | 4 | 2 | 0 | 137,00 USD | +33,72% |
CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
CureVac | 0 | 1 | 0 | - | - |
EVOTEC SE | 2 | 2 | 1 | 9,68 EUR | -2,76% |
Johnson & Johnson | 0 | 0 | 0 | - | - |
Moderna Inc | 0 | 2 | 1 | 67,33 USD | +84,77% |
MorphoSys | 1 | 3 | 0 | 35,38 EUR | - |
Novavax Inc. | 0 | 0 | 0 | - | - |
QIAGEN N.V. | 6 | 2 | 0 | 47,97 EUR | +19,39% |
Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +20,71% |
Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
Valneva | 0 | 0 | 0 | - | - |